Ranked #1
Chemotherapy for Second Line Treatment of Non-Small Cell Lung Cancer (NSCLC) (audio)
Chemotherapy for Second Line Treatment of Non-Small Cell Lung Cancer (NSCLC) (audio)
This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current ... Read more
31 Mar 2009
•
10mins
Ranked #2
ASCO Lung Cancer Highlights, Part 9: The MADeIT Study of Predictive Biomarkers for Chemotherapy in Advanced NSCLC (audio)
ASCO Lung Cancer Highlights, Part 9: The MADeIT Study of Predictive Biomarkers for Chemotherapy in Advanced NSCLC (audio)
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the results and implications of the MADeIT phase III r... Read more
23 Aug 2013
•
9mins
Ranked #3
ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)
ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint... Read more
4 Sep 2013
•
5mins
Ranked #4
Never-Smokers with Lung Cancer: A Separate Disease? (audio)
Never-Smokers with Lung Cancer: A Separate Disease? (audio)
This slide presentation by medical oncologist and lung cancer expert Dr. Jack West presents a general background on the ... Read more
21 May 2009
•
10mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
ASCO Lung Cancer Highlights, Part 8: The Biomarkers France Study (audio)
ASCO Lung Cancer Highlights, Part 8: The Biomarkers France Study (audio)
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews the landmark Biomarkers France study that tested a wi... Read more
23 Aug 2013
•
7mins
Ranked #6
Optimal Treatment of Unresectable Locally Advanced NSCLC (audio)
Optimal Treatment of Unresectable Locally Advanced NSCLC (audio)
This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the evolution of our curren... Read more
28 Feb 2009
•
10mins
Ranked #7
Antiangiogenesis in First Line NSCLC (audio)
Antiangiogenesis in First Line NSCLC (audio)
This presentation by medical oncologist and lung cancer expert Dr. Jack West introduces the concept of angiogenesis, wit... Read more
30 Jan 2009
•
9mins
Ranked #8
Janessa Laskin Interview (audio)
Janessa Laskin Interview (audio)
This interview by medical oncologist Dr. Jack West of fellow medical oncologist and lung cancer expert Dr. Janessa Laski... Read more
22 Jan 2009
•
8mins
Ranked #9
ASCO Lung Cancer Highlights, Part 6: Predicting Benefit of Chemotherapy vs. EGFR Inhibitor Therapy in Second Line (audio)
ASCO Lung Cancer Highlights, Part 6: Predicting Benefit of Chemotherapy vs. EGFR Inhibitor Therapy in Second Line (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews the results of the PROSE study of the Veristrat serum proteo... Read more
16 Aug 2013
•
6mins
Ranked #10
ASCO Lung Cancer Highlights, Part 5: Updates in Maintenance Therapy for Advanced NSCLC (audio)
ASCO Lung Cancer Highlights, Part 5: Updates in Maintenance Therapy for Advanced NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, discusses results of two important trials of maintenance therapy in ... Read more
15 Aug 2013
•
12mins
Ranked #11
ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLC (audio)
ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews a Swiss study comparing tri-modality therapy with chemoradia... Read more
14 Aug 2013
•
6mins
Ranked #12
ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for s... Read more
13 Aug 2013
•
8mins
Ranked #13
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of... Read more
11 Aug 2013
•
8mins
Ranked #14
ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)
ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)
Dr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC wit... Read more
7 Aug 2013
•
7mins
Ranked #15
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Current and Future Treatments (audio)
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Current and Future Treatments (audio)
Dr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, MI discusses the evolution of our current best tre... Read more
9 Jun 2013
•
21mins
Ranked #16
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (audio)
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (audio)
Dr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, MI reviews the impact, causes, common symptoms, an... Read more
30 May 2013
•
16mins
Ranked #17
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in e... Read more
20 May 2013
•
19mins
Ranked #18
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (audio)
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (audio)
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews early efforts in molecularly-defined staging of p... Read more
17 May 2013
•
11mins
Ranked #19
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 1): Potential Value of Molecular Staging (audio)
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 1): Potential Value of Molecular Staging (audio)
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, explains the potential utility of molecularly guided stag... Read more
13 May 2013
•
12mins
Ranked #20
Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (audio)
Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (audio)
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, summarizes evidence from the PARAMOUNT trial, demonst... Read more
7 Apr 2013
•
3mins
